Cargando…

How to select cancer patients for immunotherapy

Detalles Bibliográficos
Autores principales: Pfeiffer, Per, Qvortrup, Camilla, Hansen, Karin Holmskov
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804597/
https://www.ncbi.nlm.nih.gov/pubmed/33418504
http://dx.doi.org/10.1016/j.ebiom.2020.103184
_version_ 1783636188035284992
author Pfeiffer, Per
Qvortrup, Camilla
Hansen, Karin Holmskov
author_facet Pfeiffer, Per
Qvortrup, Camilla
Hansen, Karin Holmskov
author_sort Pfeiffer, Per
collection PubMed
description
format Online
Article
Text
id pubmed-7804597
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78045972021-01-22 How to select cancer patients for immunotherapy Pfeiffer, Per Qvortrup, Camilla Hansen, Karin Holmskov EBioMedicine Commentary Elsevier 2021-01-06 /pmc/articles/PMC7804597/ /pubmed/33418504 http://dx.doi.org/10.1016/j.ebiom.2020.103184 Text en © 2020 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
Pfeiffer, Per
Qvortrup, Camilla
Hansen, Karin Holmskov
How to select cancer patients for immunotherapy
title How to select cancer patients for immunotherapy
title_full How to select cancer patients for immunotherapy
title_fullStr How to select cancer patients for immunotherapy
title_full_unstemmed How to select cancer patients for immunotherapy
title_short How to select cancer patients for immunotherapy
title_sort how to select cancer patients for immunotherapy
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804597/
https://www.ncbi.nlm.nih.gov/pubmed/33418504
http://dx.doi.org/10.1016/j.ebiom.2020.103184
work_keys_str_mv AT pfeifferper howtoselectcancerpatientsforimmunotherapy
AT qvortrupcamilla howtoselectcancerpatientsforimmunotherapy
AT hansenkarinholmskov howtoselectcancerpatientsforimmunotherapy